The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

National University of San Martín at World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

National University of San Martín takes part in 2 sessions at World Vaccine Congress 2027 in Washington. Its sessions present ARVAC, the first COVID-19 vaccine approved in South America, from phase IV results to the immune responses its booster dose induces.

Organization	World Vaccine Congress 2027 Attendance
National University of San Martín San Martín, Argentina
unsam.edu.ar Academic Argentine public university whose researchers developed ARVAC, a recombinant protein COVID-19 vaccine.	Talk Wed Mar 10 12:25 Phase IV results of the ARVAC vaccine, the first COVID-19 vaccine approved in South America and endorsed by PAHO Pandemic Platforms Track Talk Wed Mar 10 12:40 Immune Responses Induced by the ARVAC Booster Vaccine Following Phase IV Evaluation Immune Profiling Track

Instantly find 20 buyers from National University of San Martín

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction